About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [511 citations: 101–200 of 508 articles]

Articles published in Chemotherapy Research and Practice have been cited 511 times. The following is a list of the 508 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Silviya Petrova Zustiak, Smritee Dadhwal, Carlos Medina, Sonette Steczina, Yasaman Chehreghanianzabi, Anisa Ashraf, and Prashanth Asuri, “Three-dimensional matrix stiffness and adhesive ligands affect cancer cell response to toxins,” Biotechnology and Bioengineering, 2015. View at Publisher · View at Google Scholar
  • Xiaodan Cao, Haijun Yu, Chao Chen, Jia Wei, and Ping Wang, “Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy,” Biotechnology Letters, vol. 37, no. 7, pp. 1347–1354, 2015. View at Publisher · View at Google Scholar
  • Gerwyn Morris, Michael Berk, Ken Walder, and Michael Maes, “Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses,” BMC Medicine, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kristian Barlinn, Hans Lehrach, Timo Siepmann, David Braeuer, Ulrich Buntrock, and Norbert Sassim, “Temporary loss of moral behavior in a patient undergoing chemotherapy with cisplatin - breaking bad,” Bmc Psychiatry, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Soudabeh Sabetian, and Mohd Shahir Shamsir, “Identification of putative drug targets for human sperm-egg interaction defect using protein network approach,” Bmc Systems Biology, vol. 9, 2015. View at Publisher · View at Google Scholar
  • David Balayssac, Jeremy Ferrier, Bruno Pereira, Brigitte Gillet, Caroline Petorin, Julie Vein, Frederic Libert, Alain Eschalier, and Denis Pezet, “Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, sin,” Bmj Open, vol. 5, no. 4, 2015. View at Publisher · View at Google Scholar
  • Takahisa Imamura, Mutsuko Yamamoto-Ibusuki, Aiko Sueta, Tatsuko Kubo, Atsushi Irie, Ken Kikuchi, Toru Kariu, and Hirotaka Iwase, “Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis,” Breast Cancer, 2015. View at Publisher · View at Google Scholar
  • Callie R. Merry, Sarah McMahon, Cheryl L. Thompson, Kristy L. S. Miskimen, Lyndsay N. Harris, and Ahmad M. Khalil, “Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+breast cancer,” Breast Cancer Research And Treatment, vol. 150, no. 2, pp. 321–334, 2015. View at Publisher · View at Google Scholar
  • Amelie Schramm, Nikolaus De Gregorio, Peter Widschwendter, Visnja Fink, and Jens Huober, “Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review,” Breast Care, vol. 10, no. 3, pp. 173–178, 2015. View at Publisher · View at Google Scholar
  • Khalid O Alfarouk, Christian-Martin Stock, Sophie Taylor, Megan Walsh, Abdel Khalig Muddathir, Daniel Verduzco, Adil H H Bashir, Osama Y Mohammed, Gamal O Elhassan, Salvador Harguindey, Stephan J Reshkin, Muntaser E Ibrahim, and Cyril Rauch, “Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp,” Cancer Cell International, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Ivy Paw, Richard C. Carpenter, Kounosuke Watabe, Waldemar Debinski, and Hui-Wen Lo, “Mechanisms regulating glioma invasion,” Cancer Letters, vol. 362, no. 1, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Miao Wang, Mary Topalovski, Jason E. Toombs, Christopher M. Wright, Zachary R. Moore, David A. Boothman, Hiromi Yanagisawa, Huamin Wang, Agnieszka Witkiewicz, Diego H. Castrillon, and Rolf A. Brekken, “Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer,” Cancer Research, vol. 75, no. 23, pp. 5058–5069, 2015. View at Publisher · View at Google Scholar
  • É. Le Rhun, C. Mateus, L. Mortier, F. Dhermain, B. Guillot, J.-J. Grob, C. Lebbe, M. Thomas, T. Jouary, M.-T. Leccia, and C. Robert, “Traitement systémique des métastases cérébrales de mélanome,” Cancer/Radiothérapie, 2015. View at Publisher · View at Google Scholar
  • Mireia Nager, Maria Santacana, Deepshikha Bhardwaj, Joan Valls, Isidre Ferrer, Pere Nogues, Carles Canti, and Judit Herreros, “Nuclear phosphorylated Y142 beta-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion,” Cell Cycle, vol. 14, no. 22, pp. 3644–3655, 2015. View at Publisher · View at Google Scholar
  • Belinda Halling Sorensen, Line Jee Hartmann Rasmussen, Bjorn Sindballe Broberg, Thomas Kjaer Klausen, Daniel Peter Rafael Sauter, Ian Henry Lambert, Anders Aspberg, and Else Kay Hoffmann, “Integrin beta(1), Osmosensing, and Chemoresistance in Mouse Ehrlich Carcinoma Cells,” Cellular Physiology And Biochemistry, vol. 36, no. 1, pp. 111–132, 2015. View at Publisher · View at Google Scholar
  • Yuanzeng Min, Joseph M. Caster, Michael J. Eblan, and Andrew Z. Wang, “Clinical Translation of Nanomedicine,” Chemical Reviews, pp. 150619062806005, 2015. View at Publisher · View at Google Scholar
  • Yanan Tang, Zhixin Wang, Xiaolong Yang, Junbo Chen, Linan Liu, Weian Zhao, X. Chris Le, and Feng Li, “Constructing real-time, wash-free, and reiterative sensors for cell surface proteins using binding-induced dynamic DNA assembly,” Chemical Science, vol. 6, no. 10, pp. 5729–5733, 2015. View at Publisher · View at Google Scholar
  • Richard J. Albertini, Elizabeth W. Carter, Janice A. Nicklas, Pamela M. Vacek, and Vernon E. Walker, “1,3-Butadiene, CML and the t(9:22) translocation: A reality check,” Chemico-Biological Interactions, 2015. View at Publisher · View at Google Scholar
  • Jian-Wei Zhang, Tao Qin, Shao-Dong Hong, Jing Zhang, Wen-Feng Fang, Yuan-Yuan Zhao, Yun-Peng Yang, Cong Xue, Yan Huang, Hong-Yuan Zhao, Yu-Xiang Ma, Zhi-Huang Hu, Pei-Yu Huang, and Li Zhang, “Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma,” Chinese Journal Of Cancer, vol. 34, 2015. View at Publisher · View at Google Scholar
  • Xiao-Yun Hu, Ji-Yun Liang, Xue-Jun Guo, Li Liu, and Ya-Bing Guo, “5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (Delta Psi m)-mediated apoptosis in hepato,” Clinical And Experimental Pharmacology And Physiology, vol. 42, no. 2, pp. 146–153, 2015. View at Publisher · View at Google Scholar
  • Weining Hu, and Yu Huang, “Targeting the platelet-derived growth factor signalling in cardiovascular disease,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 12, pp. 1221–1224, 2015. View at Publisher · View at Google Scholar
  • Marissa D. Friedman, Mario Lacouture, and Chau Dang, “Dermatologic Adverse Events Associated with use of Adjuvant Lapatinib in Combination with Paclitaxel and Trastuzumab for HER2 positive Breast Cancer: A Case Series Analysis,” Clinical Breast Cancer, 2015. View at Publisher · View at Google Scholar
  • Bin-Chi Liao, Yu-Yun Shao, Ho-Min Chen, Wen-Yi Shau, Zhong-Zhe Lin, Raymond Nienchen Kuo, Chiu-Ling Lai, Kuo-Hsing Chen, Ann-Lii Cheng, James Chih-Hsin Yang, and Mei-Shu Lai, “Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma,” Clinical Lung Cancer, vol. 16, no. 2, pp. 137–143, 2015. View at Publisher · View at Google Scholar
  • Mahino Fatima, Nazura Usmani, Faldha Firdaus, Mohammad Faraz Zafeer, Shafeeque Ahmad, Kafil Akhtar, S. M. Dawar Husain, Mir Hilal Ahmad, Ehraz Anis, and M. Mobarak Hossain, “In vivo induction of antioxidant response and oxidative stress associated with genotoxicity and histopathological alteration in two commercial fish sp,” Comparative Biochemistry And Physiology C-Toxicology & Pharmacology, vol. 176, pp. 17–30, 2015. View at Publisher · View at Google Scholar
  • Wolfgang Marx, Karin Ried, Alexandra L McCarthy, Luis Vitetta, Avni Sali, Daniel McKavanagh, and Elisabeth Isenring, “Ginger—Mechanism of Action in Chemotherapy-induced Nausea and Vomiting: A Review,” Critical Reviews in Food Science and Nutrition, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Christopher G. England, Chin F. Ng, Victor van Berkel, and Hermann B. Frieboes, “A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity,” Current Drug Targets, vol. 16, no. 10, pp. 1057–1087, 2015. View at Publisher · View at Google Scholar
  • Guido Cavaletti, and Paola Marmiroli, “Chemotherapy-induced peripheral neurotoxicity,” Current Opinion in Neurology, vol. 28, no. 5, pp. 500–507, 2015. View at Publisher · View at Google Scholar
  • Anatolii Romaniuk, and Mykola Lyndin, “Immune microenvironment as a factor of breast cancer progression,” Diagnostic Pathology, vol. 10, 2015. View at Publisher · View at Google Scholar
  • Geng Guo, Cheng-liang Zhong, Yang Liu, Xing-gang Mao, Zheng Zhang, Ji Jin, Jing Liu, Liu Yang, Jin-ming Mao, Yu-hong Guo, and Yuan-li Zhao, “Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas,” Disease Markers, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Mohammad Waseem, Monica Bhardwaj, Heena Tabassum, Sheikh Raisuddin, and Suhel Parvez, “Cisplatin hepatotoxicity mediated by mitochondrial stress,” Drug and Chemical Toxicology, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Raphael Tavares, Nicole M. Scherer, Carlos G. Ferreira, Fabricio F. Costa, and Fabio Passetti, “Splice variants in the proteome: a promising and challenging field to targeted drug discovery,” Drug Discovery Today, vol. 20, no. 3, pp. 353–360, 2015. View at Publisher · View at Google Scholar
  • J. Gras, “ABITUZUMAB Anti-Integrin alpha(nu) (CD51, ITGAV) MAb, Oncolytic,” Drugs Of The Future, vol. 40, no. 2, pp. 97–100, 2015. View at Publisher · View at Google Scholar
  • Sree Harsha, Bandar E. Al-Dhubiab, Anroop B. Nair, Mohammed Al-Khars, Mohammed Al-Hassan, Raja Rajan, Mahesh Attimarad, Katharigatta N. Venugopala, and Afzal Haq Asif, “Novel Drying Technology of Microsphere and Its Evaluation for Targeted Drug Delivery for Lungs,” Drying Technology, vol. 33, no. 4, pp. 502–512, 2015. View at Publisher · View at Google Scholar
  • N. van der Linden, C. W. M. van Gils, C. P. Pescott, J. Buter, M. R. Vergeer, and C. A. Uyl-de Groot, “Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck,” European Archives Of Oto-Rhino-Laryngology, vol. 272, no. 8, pp. 2007–2016, 2015. View at Publisher · View at Google Scholar
  • Manu M. Joseph, S.R. Aravind, Suraj K. George, K. Raveendran Pillai, S. Mini, and T.T. Sreelekha, “Anticancer activity of galactoxyloglucan polysaccharide–conjugated doxorubicin nanoparticles: mechanistic insights and interactome analysis,” European Journal of Pharmaceutics and Biopharmaceutics, 2015. View at Publisher · View at Google Scholar
  • Pamela Ovadje, Alessia Roma, Matthew Steckle, Leah Nicoletti, John Thor Arnason, and Siyaram Pandey, “Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Giovanni Sortino, Francesco Passiglia, Sergio Rizzo, Francesca Lo Vullo, Antonio Galvano, Viviana Bazan, Christian Rolfo, Antonio Russo, and Giuseppe Bronte, “Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario,” Expert Opinion On Biological Therapy, vol. 15, no. 1, pp. 45–59, 2015. View at Publisher · View at Google Scholar
  • Laura Poupon, Nicolas Kerckhove, Julie Vein, Sylvain Lamoine, Nicolas Authier, Jerome Busserolles, and David Balayssac, “Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives,” Expert Opinion On Drug Safety, vol. 14, no. 8, pp. 1269–1282, 2015. View at Publisher · View at Google Scholar
  • Hani J. Alturkmani, Ziyan Y. Pessetto, and Andrew K. Godwin, “Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor,” Expert Opinion On Investigational Drugs, vol. 24, no. 8, pp. 1045–1058, 2015. View at Publisher · View at Google Scholar
  • Fiona Taylor, and Barry W. Hancock, “Pharmacotherapy of placental site and epithelioid trophoblastic tumours,” Expert Opinion On Orphan Drugs, vol. 3, no. 1, pp. 75–85, 2015. View at Publisher · View at Google Scholar
  • Rosalba D'Alessandro, Caterina Messa, Maria Grazia Refolo, and Brian I. Carr, “Modulation of sensitivity and resistance tomultikinase inhibitors by microenvironmental platelet factors in HCC,” Expert Opinion On Pharmacotherapy, vol. 16, no. 18, pp. 2773–2780, 2015. View at Publisher · View at Google Scholar
  • Francesca Musumeci, Silvia Schenone, Giancarlo Grossi, Chiara Brullo, and Monica Sanna, “Analogs, formulations and derivatives of imatinib: a patent review,” Expert Opinion On Therapeutic Patents, vol. 25, no. 12, pp. 1411–1421, 2015. View at Publisher · View at Google Scholar
  • Sreena Raj, and K.M. Gothandam, “Immunomodulatory activity of methanolic extract of Amorphophallus commutatus var. wayanadensis under normal and cyclophosphamide induced immunosuppressive conditions in mice models,” Food and Chemical Toxicology, 2015. View at Publisher · View at Google Scholar
  • Rima H. Hanna-Wakim, Soha T. Ghanem, Mona W. El Helou, Sarah A. Khafaja, Rouba A. Shaker, Sara A. Hassan, Randa K. Saad, Carine P. Hedari, Rima W. Khinkarly, Farah M. Hajar, Marwan Bakhash, Dima El Karah, Imad S. Akel, Mariam A. Rajab, Mireille Khoury, and Ghassan S. Dbaibo, “Epidemiology and characteristics of urinary tract infections in children and adolescents,” Frontiers in Cellular and Infection Microbiology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Mohammed Akli Ayoub, Flavie Landomiel, Nathalie Gallay, Gwenhael Jégot, Anne Poupon, Pascale Crépieux, and Eric Reiter, “Assessing Gonadotropin Receptor Function by Resonance Energy Transfer-Based Assays,” Frontiers in Endocrinology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Nicolas S. Merle, Remi Noe, Lise Halbwachs-Mecarelli, Veronique Fremeaux-Bacchi, and Lubka T. Roumenina, “Complement System Part II: Role in Immunity,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Anne Davin-Regli, and Jean-Marie Pagès, “Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment,” Frontiers in Microbiology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Anne-Florence Blandin, Guillaume Renner, Maxime Lehmann, Isabelle Lelong-Rebel, Sophie Martin, and Monique Dontenwill, “β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer,” Frontiers in Pharmacology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Saliha Harrach, and Giuliano Ciarimboli, “Role of transporters in the distribution of platinum-based drugs,” Frontiers In Pharmacology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • R. Liang, Y. Lin, Z. H. Liu, X. L. Liao, C. L. Yuan, S. N. Liao, and Y. Q. Li, “Correlation between ERCC1 expression and concurrent chemotherapy and radiotherapy in patients with locally advanced nasopharyngeal cancer,” Genetics And Molecular Research, vol. 14, no. 2, pp. 5804–5811, 2015. View at Publisher · View at Google Scholar
  • Matthias Kreppel, Nilofar-Natalie Amir Manawi, Martin Scheer, Hans-Joachim Nickenig, Daniel Rothamel, Timo Dreiseidler, Uta Drebber, Max Zinser, Joachim E. Zoeller, Orlando Guntinas-Lichius, and Simon Florian Preuss, “Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, 7th edition, for cancer of the ,” Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck, vol. 37, no. 3, pp. 400–406, 2015. View at Publisher · View at Google Scholar
  • Ana-Iris Schiefer, Ildiko Mesteri, Anna S. Berghoff, Andrea Haitel, Manuela Schmidinger, Matthias Preusser, and Peter Birner, “Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor,” Histopathology, vol. 67, no. 6, pp. 799–805, 2015. View at Publisher · View at Google Scholar
  • Sachiko Matsuzaki, and Claude Darcha, “Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro,” Human Reproduction, vol. 30, no. 7, pp. 1606–1616, 2015. View at Publisher · View at Google Scholar
  • Xiaofang Hu, Yan Cao, Yiming Meng, and Mingxiao Hou, “A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2),” Human Vaccines & Immunotherapeutics, vol. 11, no. 2, pp. 516–521, 2015. View at Publisher · View at Google Scholar
  • Kumutnart Chanprapaph, Padcha Pongcharoen, and Vasanop Vachiramon, “Cutaneous adverse events of epidermal growth factor receptor inhibitors: A retrospective review of 99 cases,” Indian Journal Of Dermatology Venereology & Leprology, vol. 81, no. 5, 2015. View at Publisher · View at Google Scholar
  • Kumar Prabhash, Amit Joshi, Nidhi Tandon, Vanita Noronha, Sachin Dhumal, Vijay Patil, Supreeta Arya, Shashikant Juvekar, Jaiprakash Agarwal, Anil DCruz, and Prathmesh Pai, “Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal,” Indian Journal of Medical and Paediatric Oncology, vol. 36, no. 3, pp. 172, 2015. View at Publisher · View at Google Scholar
  • Jiao Yang, Wei Li, Feifei Luo, Naiqing Zhao, Wen Zhang, Dan Zhang, Jiawen Qian, Yiwei Yu, Xiujuan Zheng, Yan Wang, Yi Feng, Tianshu Liu, and Yiwei Chu, “Low percentage of CD24(hi)CD27(+)CD19(+) B cells decelerates gastric cancer progression in XELOX-treated patients,” International Immunopharmacology, vol. 26, no. 2, pp. 322–327, 2015. View at Publisher · View at Google Scholar
  • Satvir Sekhon-Loodu, Ziaullah, and H.P. Vasantha Rupasinghe, “Docosahexaenoic acid ester of phloridzin inhibit lipopolysaccharide-induced inflammation in THP-1 differentiated macrophages,” International Immunopharmacology, 2015. View at Publisher · View at Google Scholar
  • Nanxin Li, Yanni Hao, Jipan Xie, Peggy L. Lin, Valerie Koo, Erika Ohashi, and Eric Q. Wu, “Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study,” International Journal of Breast Cancer, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Valeria Maria Piccolini, Alessandra Esposito, Veronica Dal Bo, Violetta Insolia, Maria Grazia Bottone, Sandra Angelica De Pascali, Francesco Paolo Fanizzi, and Graziella Bernocchi, “Cerebellum neurotransmission during postnatal development: [Pt(O,O '-acac)(gamma-acac)(DMS)] vs cisplatin and neurotoxicity,” International Journal Of Developmental Neuroscience, vol. 40, pp. 24–34, 2015. View at Publisher · View at Google Scholar
  • Vinodh Kumar Radhakrishnan, Lorraine Christine Hernandez, Kendra Anderson, Qianwei Tan, Marino De León, and Daisy D. De León, “Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients,” International Journal of Endocrinology, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Maria Joao Fraqueza, “Antibiotic resistance of lactic acid bacteria isolated from dry-fermented sausages,” International Journal Of Food Microbiology, vol. 212, pp. 76–88, 2015. View at Publisher · View at Google Scholar
  • Wail A. Hayajneh, Aline Hajj, Fawzi Hulliel, Dolla Karam Sarkis, Noha Irani-Hakimeh, Lama Kazan, and Robert E. Badal, “Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011–2013,” International Journal of Infectious Diseases, 2015. View at Publisher · View at Google Scholar
  • Jana Jaal, Marju Kase, Ave Minajeva, Mikk Saretok, Aidi Adamson, Jelizaveta Junninen, Tõnis Metsaots, Tõnu Jõgi, Madis Joonsalu, Markus Vardja, and Toomas Asser, “VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment,” International Journal of Inflammation, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • N Ubanako Philemon, Choene Mpho, and Motadi Lesetja, “Mechanisms of apoptosis in ovarian cancer: The small molecule targeting,” International Journal of Medicine and Medical Sciences, vol. 7, no. 3, pp. 46–60, 2015. View at Publisher · View at Google Scholar
  • Byeong Mo Kim, Yunkyung Hong, Seunghoon Lee, Pengda Liu, Ji Hong Lim, Yong Heon Lee, Tae Ho Lee, Kyu Tae Chang, and Yonggeun Hong, “Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy,” International Journal Of Molecular Sciences, vol. 16, no. 11, pp. 26880–26913, 2015. View at Publisher · View at Google Scholar
  • Ewa Maj, Beata Filip-Psurska, Marta Świtalska, Andrzej Kutner, and Joanna Wietrzyk, “Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model,” International Journal of Molecular Sciences, vol. 16, no. 11, pp. 27191–27207, 2015. View at Publisher · View at Google Scholar
  • Andrea Mathe, Rodney Scott, and Kelly Avery-Kiejda, “miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 28347–28376, 2015. View at Publisher · View at Google Scholar
  • Giuseppina Bozzuto, and Agnese Molinari, “Liposomes as nanomedical devices,” International Journal of Nanomedicine, vol. 10, pp. 975–999, 2015. View at Publisher · View at Google Scholar
  • Jie Tang, Fuchun Guo, Yang Du, Xiaoling Liu, Qing Qin, Xiaoke Liu, Tao Yin, Li Jiang, and Yongsheng Wang, “Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activat,” International Journal Of Oncology, vol. 46, no. 5, pp. 2083–2095, 2015. View at Publisher · View at Google Scholar
  • Dong Ho Park, Hyo Sung Jeon, Soo Young Lee, Yi Young Choi, Hae Woo Lee, Seongkyu Yoon, Jae Chel Lee, Yoo Sang Yoon, Dae Sung Kim, Moon Jun Na, Sun Jung Kwon, Dong Sun Kim, Jaeku Kang, Jae Yong Park, and Ji Woong Son, “MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2,” International Journal Of Oncology, vol. 47, no. 4, pp. 1545–1553, 2015. View at Publisher · View at Google Scholar
  • Matthew M. Kwok, and Paul Goodyear, “Prognostic and Predictive Protein Biomarkers in Laryngeal Squamous Cell Carcinoma—A Systematic Review,” International Journal of Otolaryngology and Head & Neck Surgery, vol. 04, no. 03, pp. 180–189, 2015. View at Publisher · View at Google Scholar
  • N. N. Basu, L. Barr, G. L. Ross, and D. G. Evans, “Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies,” International Journal of Surgical Oncology, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Jing Liu, Nur P. Damayanti, Il-Hoon Cho, Yesim Polar, Sunil Badve, and Joseph M. K. Irudayaraj, “Single-cell screening and quantification of transcripts in cancer tissues by second-harmonic generation microscopy,” Journal Of Biomedical Optics, vol. 20, no. 9, 2015. View at Publisher · View at Google Scholar
  • Masaaki Kawai, Akio Nakashima, Shinji Kamada, and Ushio Kikkawa, “Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family,” Journal Of Biomedical Science, vol. 22, 2015. View at Publisher · View at Google Scholar
  • B. Ravi Shankar, Poojar Kiran, B. V. Madhavi, and E. Vijay, “Concurrent Nimotuzumab with Radiation Therapy in Locally Advanced Cancers of Oropharynx and Hypopharynx: A Review of 6 Cases,” Journal of Cancer Therapy, vol. 06, no. 04, pp. 390–398, 2015. View at Publisher · View at Google Scholar
  • Stephen Goodall, Martina L. Jones, and Stephen Mahler, “Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy-future prospects,” Journal Of Chemical Technology And Biotechnology, vol. 90, no. 7, pp. 1169–1176, 2015. View at Publisher · View at Google Scholar
  • Chujie Bai, Min Yang, Zhengfu Fan, Shu Li, Tian Gao, and Zhiwei Fang, “Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of,” Journal Of Experimental & Clinical Cancer Research, vol. 34, 2015. View at Publisher · View at Google Scholar
  • Milena Milutinovic, Milan Stankovic, Danijela Cvetkovic, Vuk Maksimovic, Biljana Smit, Radoslav Pavlovic, and Snezana Markovic, “The Molecular Mechanisms of Apoptosis Induced by Allium flavumL. and Synergistic Effects with New-Synthesized Pd(II) Complex on Colon Cancer Cells,” Journal Of Food Biochemistry, vol. 39, no. 3, pp. 238–250, 2015. View at Publisher · View at Google Scholar
  • Poonam Sharma, Sudhir Kumar Tomar, Vikas Sangwan, Pawas Goswami, and Rameshwar Singh, “ Antibiotic Resistance of Lactobacillus sp. Isolated from Commercial Probiotic Preparations ,” Journal of Food Safety, 2015. View at Publisher · View at Google Scholar
  • Jelena Katanić, Vladimir Mihailović, Sanja Matić, Vesna Stanković, Nevena Stanković, Tatjana Boroja, Milan Mladenović, Snežana Stanić, Samo Kreft, and Mirjana Mihailović, “The ameliorating effect of Filipendula hexapetala extracts on hepatorenal toxicity of cisplatin,” Journal of Functional Foods, vol. 18, pp. 198–212, 2015. View at Publisher · View at Google Scholar
  • Koji Matsuo, Seiji Mabuchi, Mika Okazawa, Mahiru Kawano, Hiromasa Kuroda, Shoji Kamiura, and Tadashi Kimura, “Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors,” Journal Of Gynecologic Oncology, vol. 26, no. 1, pp. 3–11, 2015. View at Publisher · View at Google Scholar
  • Federica Maria Di Maggio, Luigi Minafra, Giusi Irma Forte, Francesco Paolo Cammarata, Domenico Lio, Cristina Messa, Maria Carla Gilardi, and Valentina Bravatà, “Portrait of inflammatory response to ionizing radiation treatment,” Journal of Inflammation, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Xu Liu, Alvin Kung, Brock Malinoski, G. K. Surya Prakash, and Chao Zhang, “Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase,” Journal of Medicinal Chemistry, 2015. View at Publisher · View at Google Scholar
  • Rajath Othayoth, Pardhasaradhi Mathi, Khaggeswar Bheemanapally, Lavanya Kakarla, and Mahendran Botlagunta, “Characterization of vitamin-cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue,” Journal Of Microencapsulation, vol. 32, no. 6, pp. 578–588, 2015. View at Publisher · View at Google Scholar
  • Yuanyuan Zhu, and Lianming Liao, “Applications of Nanoparticles for Anticancer Drug Delivery: A Review,” Journal Of Nanoscience And Nanotechnology, vol. 15, no. 7, pp. 4753–4773, 2015. View at Publisher · View at Google Scholar
  • Laura Cosmai, Maurizio Gallieni, and Camillo Porta, “Renal toxicity of anticancer agents targeting HER2 and EGFR,” Journal Of Nephrology, vol. 28, no. 6, pp. 647–657, 2015. View at Publisher · View at Google Scholar
  • Roberta Salaroli, Alice Ronchi, Francesca Romana Buttarelli, Filippo Cortesi, Valeria Marchese, Elena Della Bella, Cristiano Renna, Caterina Baldi, Felice Giangaspero, and Giovanna Cenacchi, “Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma,” Journal Of Neuro-Oncology, vol. 121, no. 1, pp. 119–127, 2015. View at Publisher · View at Google Scholar
  • Kevin A. Harvey, Zhidong Xu, M. Reza Saaddatzadeh, Haiyan Wang, Karen Pollok, Aaron A. Cohen-Gadol, and Rafat A. Siddiqui, “Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines,” Journal Of Neurosurgery, vol. 122, no. 3, pp. 547–556, 2015. View at Publisher · View at Google Scholar
  • Sudeshna Mukherjee, Sayan Ghosh, Dipesh Kr. Das, Priyanka Chakraborty, Sreetama Choudhury, Payal Gupta, Arghya Adhikary, Sanjit Dey, and Sreya Chattopadhyay, “Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection - synthesis, characterization and in vitro evaluation,” Journal Of Nutritional Biochemistry, vol. 26, no. 11, pp. 1283–1297, 2015. View at Publisher · View at Google Scholar
  • Joshua Seth Eaton, Paul E. Miller, Mark J. Mannis, and Christopher J. Murphy, “Ocular Adverse Events Associated with Antibody-Drug Conjugates in Human Clinical Trials,” Journal Of Ocular Pharmacology And Therapeutics, vol. 31, no. 10, pp. 589–604, 2015. View at Publisher · View at Google Scholar
  • Sunil S. Adav, Ho Hee Hwa, Dominique de Kleijn, and Siu Kwan Sze, “Improving Blood Plasma Glycoproteome Coverage by Coupling Ultracentrifugation Fractionation to Electrostatic Repulsion-Hydrophilic Interaction Chromat,” Journal Of Proteome Research, vol. 14, no. 7, pp. 2828–2838, 2015. View at Publisher · View at Google Scholar
  • Young Hak Kim, and Michiaki Mishima, “Bevacizumab in Combination with Chemotherapy or Molecularly Targeted Agents for Non-Small-Cell Lung Cancer with Brain Metastases,” Journal Of Thoracic Oncology, vol. 10, no. 8, pp. E76–E76, 2015. View at Publisher · View at Google Scholar
  • Marta Simo, James C. Root, Lucia Vaquero, Pablo Ripolles, Josep Jove, Tim Ahles, Arturo Navarro, Felipe Cardenal, Jordi Bruna, and Antoni Rodriguez-Fornells, “Cognitive and Brain Structural Changes in a Lung Cancer Population,” Journal Of Thoracic Oncology, vol. 10, no. 1, pp. 38–45, 2015. View at Publisher · View at Google Scholar
  • Ee Xien Ng, Miles A. Miller, Tengyang Jing, Doug A. Lauffenburger, and Chia-Hung Chen, “Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array,” Lab Chip, vol. 15, no. 4, pp. 1153–1159, 2015. View at Publisher · View at Google Scholar
  • Denis Moro-Sibilot, Egbert Smit, Javier de Castro Carpeno, Krzysztof Lesniewski-Kmak, Joachim Aerts, Rosa Villatoro, Kees Kraaij, Karim Nacerddine, Yulia Dyachkova, Karen T. Smith, Kaisa Taipale, Allicia C. Girvan, Carla Visseren-Grul, and Philipp A. Schnabel, “Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME pros,” Lung Cancer, vol. 88, no. 2, pp. 215–222, 2015. View at Publisher · View at Google Scholar
  • John Hornberger, Fred R. Hirschc, Qianyi Li, and Ray D. Page, “Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis ,” Lung Cancer, vol. 88, no. 2, pp. 223–230, 2015. View at Publisher · View at Google Scholar
  • Engy M. Aboelnaga, Mohamed A. Daoud, Entesar I. Eladl, and Amir M. Zaid, “Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm ph,” Medical Oncology, vol. 32, no. 4, 2015. View at Publisher · View at Google Scholar
  • Barbara Crone, Michael Aschner, Tanja Schwerdtle, Uwe Karst, and Julia Bornhorst, “Elemental bioimaging of Cisplatin in Caenorhabditis elegans by LA-ICP-MS,” Metallomics, vol. 7, no. 7, pp. 1189–1195, 2015. View at Publisher · View at Google Scholar
  • Sílvia Couto, José Luís Metello, Sandra Ramos, Pedro Ferreira, Raquel Ilgenfritz, Pedro Sá e Melo, and Eman Elgindy, “Gestational trophoblastic neoplasia after in vitro fertilization and embryo-transfer,” Middle East Fertility Society Journal, 2015. View at Publisher · View at Google Scholar